Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
31.21
+0.59 (1.93%)
Sep 4, 2025, 2:04 PM - Market open
Veracyte Market Cap
Veracyte has a market cap or net worth of $2.46 billion as of September 4, 2025. Its market cap has decreased by -2.69% in one year.
Market Cap
2.46B
Enterprise Value
2.18B
1-Year Change
-2.69%
Ranking
Category
Stock Price
$31.21
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $2.46B, an increase of 795.78%. That is a compound annual growth rate of 20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 2.41B | -21.51% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
| Oct 30, 2013 | 274.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |